15 March 2026 — Novogene today celebrates its 15th anniversary, marking a milestone in its journey of supporting scientific discovery and innovation worldwide.

Over the past fifteen years, the life sciences sector has experienced rapid transformation. Advances in sequencing technologies have made large-scale research more accessible, while scientific platforms have evolved from single-omics approaches to integrated multi-omics strategies. These developments have enabled deeper biological insight and contributed to the growing role of genomic technologies in clinical practice, supporting the expansion of precision medicine.

At the same time, automation and intelligent systems have improved efficiency across research workflows. The continued growth of biological data, together with advances in artificial intelligence, is opening new opportunities for discovery and innovation across the research community.

During this period, Novogene has expanded its capabilities in step with these developments. Building on its early focus on next-generation sequencing, the company has developed a broad portfolio of multi-omics services and strengthened its laboratory network. Today, with ten local laboratories worldwide, Novogene supports researchers by providing access to advanced technologies and scalable data solutions designed to facilitate complex research projects.

Novogene’s work spans both basic research and clinical applications, particularly in areas such as oncology and genetic disease. Continued investment in automation and bioinformatics helps improve consistency, efficiency and the interpretation of increasingly complex datasets. The company is also exploring how artificial intelligence may further support the research process, from experimental planning to knowledge generation.

As Novogene marks this milestone, the company remains committed to supporting researchers as a trusted partner in advancing life science innovation.